These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15878894)

  • 21. Treating coagulopathy in liver disease with plasma transfusions or recombinant factor VIIa: an evidence-based review.
    Ramsey G
    Best Pract Res Clin Haematol; 2006; 19(1):113-26. PubMed ID: 16377545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bivalirudin for anticoagulation during hypothermic cardiopulmonary bypass and recombinant factor VIIa for iatrogenic coagulopathy.
    Nagle EL; Tsu LV; Dager WE
    Ann Pharmacother; 2011 Sep; 45(9):e47. PubMed ID: 21862711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic factor VIIa concentrate to treat coagulopathy and gastrointestinal bleeding in an infant with end-stage liver disease.
    Tobias JD; Berkenbosch JW
    Clin Pediatr (Phila); 2002 Oct; 41(8):613-6. PubMed ID: 12403380
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of recombinant factor VIIa in infants with severe coagulopathy.
    Fontaine MJ; Lazarchick J; Taylor S; Annibale D
    J Perinatol; 2004 May; 24(5):310-1. PubMed ID: 15116125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant factor VIIa for the correction of coagulopathy before emergent craniotomy in blunt trauma patients.
    Brown CV; Foulkrod KH; Lopez D; Stokes J; Villareal J; Foarde K; Curry E; Coopwood B
    J Trauma; 2010 Feb; 68(2):348-52. PubMed ID: 20154547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention and treatment of major blood loss.
    Mannucci PM; Levi M
    N Engl J Med; 2007 May; 356(22):2301-11. PubMed ID: 17538089
    [No Abstract]   [Full Text] [Related]  

  • 27. Recombinant factor VIIa. An update on its clinical use.
    Franchini M; Zaffanello M; Veneri D
    Thromb Haemost; 2005 Jun; 93(6):1027-35. PubMed ID: 15968384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrinogen and FXIII dose response effects on albumin-induced coagulopathy.
    Hanna J; Winstedt D; Schött U
    Scand J Clin Lab Invest; 2013 Oct; 73(7):553-62. PubMed ID: 24004348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of recombinant-activated factor VII in bleeding trauma patients.
    Dutton RP; Conti BM
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):299-304. PubMed ID: 19295430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of small-dose recombinant human coagulation factor VIIa for coagulopathy in patients with isolated traumatic brain injury].
    Pei BB; Li CY; Lu X; Wu X; Gao L; Yu J; Wu XH; Jin Y; Sun YR; Du ZY; Mao Y; Hu J; Zhou LF
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(23):1780-3. PubMed ID: 24124708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A critical appraisal of the use of recombinant factor VIIa in acquired bleeding conditions.
    Mittal S; Watson HG
    Br J Haematol; 2006 May; 133(4):355-63. PubMed ID: 16643441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant factor VIIa is effective at reversing coagulopathy in a lactic acidosis model.
    Lesperance RN; Lehmann RK; Harold DM; Beekley AC; Sebesta JA; Martin MJ
    J Trauma Acute Care Surg; 2012 Jan; 72(1):123-9. PubMed ID: 22002618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate.
    Fenger-Eriksen C; Anker-Møller E; Heslop J; Ingerslev J; Sørensen B
    Br J Anaesth; 2005 Mar; 94(3):324-9. PubMed ID: 15608046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current world literature. Trauma and transfusion.
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):321-5. PubMed ID: 19399963
    [No Abstract]   [Full Text] [Related]  

  • 35. Combined fresh frozen plasma with recombinant factor VIIa in restoring hemostasis for invasive procedures in children with liver diseases.
    Chuansumrit A; Treepongkaruna S; Phuapradit P
    Thromb Haemost; 2001 Apr; 85(4):748-9. PubMed ID: 11341519
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical analysis of recombinant activated factor VIIa for 18 patients with severe bleeding].
    Liu ZL; Yang L; Liu MM; Bai O; Cui JW; Li PT; Li W
    Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):409-11. PubMed ID: 22781803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmune haemophilia.
    Mannucci PM
    Blood Transfus; 2008 Jan; 6(1):6-7. PubMed ID: 18661917
    [No Abstract]   [Full Text] [Related]  

  • 38. Recombinant Factor VIIa Reduces Bleeding after Blunt Liver Injury in a Pig Model of Dilutional Coagulopathy under Severe Hypothermia.
    Spronk HM; Braunschweig T; Rossaint R; Wüst DC; van Oerle R; Lauritzen B; Tolba R; Grottke O
    PLoS One; 2015; 10(6):e0113979. PubMed ID: 26098426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Albumin-induced coagulopathy is less severe and more effectively reversed with fibrinogen concentrate than is synthetic colloid-induced coagulopathy.
    Winstedt D; Hanna J; Schött U
    Scand J Clin Lab Invest; 2013 Mar; 73(2):161-9. PubMed ID: 23368782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor IX complex for the correction of traumatic coagulopathy.
    Joseph B; Amini A; Friese RS; Houdek M; Hays D; Kulvatunyou N; Wynne J; O'Keeffe T; Latifi R; Rhee P
    J Trauma Acute Care Surg; 2012 Apr; 72(4):828-34. PubMed ID: 22491593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.